Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Modulith SL-20 ü¿ÜÃæ°ÝÆļ⼮±â¸¦ ÀÌ¿ëÇÑ ¿ä·Î°á¼® 750·ÊÀÇ ÀÓ»ó°æÇè Clinical Experience of Extracorporeal Shock Wave Lithotripsy with Modulith SL-20 in 750 Urinary Calculi

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 2È£ p.141 ~ 148
ÀÓÀ缺, À̺À±Ô,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÓÀ缺 (  ) 
Ãæ³²´ëÇб³

À̺À±Ô (  ) 
Ãæ³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

°á·Ð
1994³â 1¿ùºÎÅÍ 1997³â 6¿ù±îÁö Ãæ³²´ëÇб³º´¿ø ºñ´¢±â°ú¿¡ ¿ä·Î°á¼®À¸·Î ³»¿øÇÑ È¯ÀÚÁß
´ë±â¿ä¹ýÀÌ °¡´ÉÇÑ 4mm ÀÌÇÏ¿¡¼­ »óºÎ¿ä·ÎÀÇ ±â´ÉÀå¾Ö°¡ ¾ø°Å³ª ÀÚ°¢ÀûÀÎ Áõ»óÀÌ ¾ø´Â ȯ
ÀÚ¸¦ Á¦¿ÜÇÑ È¯ÀÚ¿¡¼­ ü¿ÜÃæ°ÝÆļ⼮¼úÀ» ½Ã¼ú¹ÞÀº ȯÀÚ Áß ÃßÀû °Ë»ç°¡ °¡´ÉÇÏ¿´´ø 750·Ê
¸¦ ´ë»óÀ¸·Î ȯÀÚÀÇ ¼ºº° ¹× ¿¬·ÉºÐÆ÷, °á¼®ÀÇ À§Ä¡ ¹× Å©±â¿¡ µû¸¥ Ä¡·áȽ¼ö ¹× ¼º°ø·ü, ½Å
³ì°¢¼®¿¡¼­ÀÇ ¿ä°üºÎ¸ñÀÇ À¯¿ë¼º, Ä¡·á ÈÄ ÇÕº´Áõ ½ÇÆÐÀÇ ¿øÀÎ µî¿¡ ´ëÇؼ­ ¿¬±¸ÇÑ °á°ú ´Ù
À½°ú °°Àº °á·ÐÀ» ¾ò¾ú´Ù.
1. 750·Ê Áß ¿¬·Éº° ºÐÆ÷´Â 30´ë¿¡¼­ 50´ë »çÀÌ¿¡ ÀüüÀÇ 72.5%¸¦ Â÷ÁöÇÏ¿´°í, ³²³àÀÇ ¼º
ºñ´Â 1.5:1·Î ³²ÀÚ°¡ ¾à°£ ¸¹¾Ò´Ù.
2. °á¼®ÀÇ À§Ä¡º° ºÐÆ÷´Â ½Å°á¼® 172·Ê(23.0%), ¿ä°ü°á¼® 529·Ê(70.4%), ½Å°á¼® ¹× ¿ä°ü°á
¼®ÀÌ ÇÔ²² ÀÖ´Â °æ¿ì 14·Ê (1.9%), ¹æ±¤°á¼® 35·Ê (4.7%)À̾ú´Ù.
3. °á¼®ÀÇ Å©±â´Â 6-l0mm°¡ 558·Ê (74.4%), 11-20mm°¡ 139·Ê ()8.6%), 31-30mm°¡ 28·Ê
(3.7%), 31-60mm°¡ 25·Ê (3.3%)À̾ú´Ù.
4. °á¼®ÀÇ Æò±Õ Ä¡·áȽ¼ö´Â 2.8ȸ¿´°í, 1ȸÀÎ °æ¿ì°¡ 380·Ê(50.6%)·Î °¡Àå ¸¹¾Ò°í, 5ȸ ÀÌÇÏ
°¡ 666·Ê·Î ÀüüÀÇ 88.8%À» Â÷ÁöÇÏ¿´´Ù. ¿ä°ü°á¼®º¸´Ù ½Å°á¼®¿¡¼­ Ä¡·áȽ¼ö°¡ ¸¹¾ÒÀ¸¸ç, Ư
È÷ ½Å³ì°¢¼®¿¡¼­ 8.3ȸ·Î °¡Àå ¸¹Àº ½Ã¼úÀ» ½ÃÇàÇÏ¿´´Ù.
5.°á¼®ÀÇ À§Ä¡¿¡ µû¸¥ ¼º°ø·ü
°á¼®ÀÇ À§Ä¡¿¡ µû¸¥ ¼º°ø·üÀº ½Å°á¼®Àº 76.2%(½Å¹è°á¼® 86.0%, ½Å¿ì°á¼® 91.1%, ¿ÏÀü ³ì°¢
¼® 50.0%, ºÎºÐ ³ì°¢¼® 53.7%)À̾úÀ¸¸ç, ¿ä°ü°á¼®Àº 98.1%(»óºÎ¿ä°ü°á¼® 96.9%, Áߺοä°ü°á
¼® 97.1%, ÇϺοä°ü°á¼® 99.3%)À̾úÀ¸¸ç, ½Å°á¼® ¹× ¿ä°ü°á¼®ÀÌ ÇÔ²² ÀÖ´Â °æ¿ì 84..3%À̾ú
°í, ¹æ±¤°á¼®Àº 714%À̾ú´Ù. °á¼®ÀÇ Å©±â¿¡ µû¸¥ ¼º°ø·üÀº 10mm ÀÌÇÏ´Â 98.0%, 11-20mm
´Â 82.0%, 21-30mm´Â 46.4%, 3)mm ÀÌ »óÀº 40.0%À̾ú´Ù.
6. ºÎºÐ ³ì°¢¼®¿¡¼­ ¿ä°üºÎ¸ñÀ» À¯Ä¡ÇÑ ±º°ú À¯Ä¡ÇÏÁö ¾ÊÀº ±º¿¡¼­ ¼â¼®¼úÀÇ ¼º°ø·üÀº °¢
°¢ 60.0%, 43.8%À̾úÀ¸¸ç, ¼â¼®¼ú ÈÄ Ãøº¹ºÎ µ¿Åë, ¿À½É ¹× ±¸Åä, ¼®·Î Çö»óÀÌ ¿ä°üºÎ¸ñÀ»
¼³Ä¡ÇÑ ±º¿¡¼­ Àû°Ô ¹ß»ýÇÏ¿´´Ù.
7. ü¿ÜÃæ°ÝÆļ⼮¼ú ÈÄ ¹ß»ýÇÑ ÇÕº´ÁõÀº À°¾ÈÀû Ç÷´¢ 522·Ê(69.6%), Ãøº¹ºÎ µ¿Åë 101·Ê
(13.4%), ¿À½É ¹× ±¸Åä 63·Ê(8.4%), ¹ß¿­ 14·Ê (1.9%), °á¼®·Î 9·Ê (1.2%), ½ÅÁÖÀ§ Ç÷Á¾ 5·Ê
(0.7%), ¿äµ¶Áõ 1·Ê(0.1%)À̾ú´Ù.
8. ü¿ÜÃæ°ÝÆļ⼮¼úÀÇ ½ÇÆпøÀÎÀº °Å´ë°á¼® 20·Ê, ºÐ¼â ÈÄ ÇϺνŹ迡¼­ ¹èÃâÀÌ ¿ëÀÌÇÏÁö
¾ÊÀº °æ¿ì 10·Ê, ¹æ±¤°á¼® 10·Ê, ¸Åº¹°á¼® 8·Ê, ½Å¹è°Ô½Ç³» °á¼® 7·Ê, ½Å´©µÎºÎ ÇùÂø 5·Ê, ¼®
·ÎÇö»ó 4·Ê, ¿äÆÇ·ù³» °á¼® 1·Ê,ȯÀÚ°¡ ¼ö¼úÀ» ¿øÇÏ´Â °æ¿ì 1·ÊÀ̾ú´Ù.
ÀÌ»óÀÇ °á°ú·Î º¼ ¶§ ¿ä·Î°á¼®ÀÇ Ä¡·á¿¡ ÀÖ¾ú¼­ ü¿ÜÃæ°ÝÆļ⼮¼úÀº °á¼®ÀÇ À§Ä¡¿Í Å©±â¿¡
°ü°è¾øÀÌ ºñ±³Àû ¾ÈÀüÇÏ°í È¿°úÀûÀÎ ÀÏÂ÷Àû Ä¡·á¹æ¹ýÀ¸·Î ¼±ÅÃÇÒ ¼ö ÀÖÀ½À» È®ÀÎÇÏ¿´´Ù. ÀÌ
¿Í ÇÔ²² ¹Ýº¹ÀûÀÎ ½Ã¼ú¿¡µµ °á¼®ÀÌ ºÐ¼âµÇÁö ¾ÊÀ» °æ¿ì, °Å´ë°á¼®, ÇغÎÇÐÀû ¹èÃâ Àå¾ÖÀÎ °æ
¿ì¿¡´Â Ä¡·á¹æ¹ýÀ» ÀüȯÇϰųª, °æÇÇÀû ½Å¼â¼®¼ú ¹× ¿ä°ü°æÀ» ÀÌ¿ëÇÑ °á¼® Á¦°Å¼úÀ» ÀÌ¿ëÇÏ
¿© ¿ä·á°á¼®À» Ä¡·áÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î »ç·áµÈ´Ù.
#ÃÊ·Ï#
Purpose: Extracorporeal shock wave lithotripsy(ESWL) has been established as the
first line procedure of urinary stone treatment. We studied retrospectively to evaluate
the effectiveness of ESWL.
Material and Methods: ESWL was performed in 750 cases with Modulith SL-20
electromagnetic lithotriptor from January, 1994 to June, 1997 in our Department of
Urology.
Result : Most patients were distributed between the fourth and sixth decades 72.5%),
and male to female ratio was 1.47:1. There were 750 cases of urinary stones: 172 cases
of renal stone(23.0%), 529 cases of ureteral stone(70.4%), 14 cases of renal and ureteral
stone(1.9%), 35 cases(4.7%) of bladder stone, and range of size was 5mm-60mm in
diameter The success rate according to stone location was 76.2% In renal stone, 98.1%
in ureter stone, 84.3% in renal and ureteral stone, and 71.4% In bladder stone. The
success rate according to stone size measured on the KUB and sonography was 98.0%
in 5-10mm, 82.0% in 11-20mm, 46.4% in 21-30mm and 40.0% over 31mm. The average
number of sessions was 2.8 sessions. Of 59 cases of staghorn calculi, 16 were treated
without preoperative silicone ureteral stenting, while 43 were treated with preoperative
silicone ureteral stunting. The complications were gross hematuria(69.6%), flank
pain(13.4%), nausea & vomiting(8.4%), fever(1.9%), steinstrasse(1.2%), perirenal
hematoma(0.7%) and uremia(0.1%). The failure rate was 8.8%. The causes of failure
were large stone(2.67%), difficulty in eliminating lower caliceal stones(1.33%), bladder
stone(1.33%), impact stone(1.07%), caliceal diverticulum(0.93%), infundibular
stenosis(0.67%), steinstrasse(0.53%), ureterocele(0.13%), and patient's desire for
operation(0.13%).
Conclusions: ESWL is considered to be a safe and non-invasive treatment method.
ESWL therapy is less effective for stones larger than 2cm(43.4%), staghorn
calculi(52.5%) or the presence of anatomical obstructions.

Å°¿öµå

Extracorporeal shock wave lithotripsy; Urinary stones;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS